COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,784 Articles (22,523 medRxiv, 8,261 bioRxiv)

Most recent first Previous |  Page 2530: Articles 25291-25300  | Next

Global years of life lost to COVID-19
Pifarre i Arolas, H., Myrskylä, M., Lo, A., Acosta, E., Lopez Casasnovas, G., Nicodemo, C., Riffe, T.
10.1101/2020.06.19.20136069 — Posted: 2020-06-20 Discussion: Onsite
Belgian Covid-19 Mortality, Excess Deaths, Number of Deaths per Million, and Infection Fatality Rates (8 March - 9 May 2020)
Molenberghs, G., Faes, C., Aerts, J., Theeten, H., Devleesschauwer, B., Bustos Sierra, N., Braeye, T., Renard, F., Herzog, S., Lusyne, P., Van der Heyden, J., Van Oyen, H., Van Damme, P., Hens, N.
10.1101/2020.06.20.20136234 — Posted: 2020-06-20
Sewage surveillance for the presence of SARS-CoV-2 genome as a useful wastewater based epidemiology (WBE) tracking tool in India
Arora, S., Nag, A., Sethi, J., Rajvanshi, J., Saxena, S., Shrivastava, S. K., Gupta, A. B.
10.1101/2020.06.18.20135277 — Posted: 2020-06-20
Clinical Sensitivity and Interpretation of PCR and Serological COVID-19 Diagnostics for Patients Presenting to the Hospital
Miller, T. E., Garcia Beltran, W. F., Bard, A. Z., Gogakos, T., Anahtar, M. N., Astudillo, M. G., Yang, D., Thierauf, J., Fisch, A. S., Mahowald, G. K., Fitzpatrick, M. J., Nardi, V., Feldman, J., Hauser, B. M., Caradonna, T. M., Marble, H. D., Ritterhouse, L. L., Turbett, S. E., Batten, J., Georgantas, N. Z., Alter, G., Schmidt, A. G., Harris, J. B., Gelfand, J. A., Poznansky, M. C., Bernstein, B. E., Louis, D. N., Dighe, A., Charles, R. C., Ryan, E. T., Branda, J. A., Pierce, V. M., Murali, M. R., Iafrate, A. J., Rosenberg, E. S., Lennerz, J.
10.1101/2020.06.19.20135723 — Posted: 2020-06-20
COVID-19 and first trimester spontaneous abortion: a case-control study of 225 pregnant patients
Cosma, S., Carosso, A., Cusato, J., Borella, F., Carosso, M., Bovetti, M., Filippini, C., D'Avolio, A., Ghisetti, V., Di Perri, G., Benedetto, C.
10.1101/2020.06.19.20135749 — Posted: 2020-06-20
SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected, hospitalized COVID-19 patients
Klimstra, W. B., Tilston-Lunel, N. L., Nambulli, S., Boslett, J., McMillen, C. M., Gilliland, T., Dunn, M. D., Sun, C., Wheeler, S. E., Wells, A., Hartman, A. L., McElroy, A. K., Reed, D. S., Rennick, L. J., Duprex, W. P.
10.1101/2020.06.19.154930 — Posted: 2020-06-20
Rapid Inactivation of SARS-CoV-2 by Silicon Nitride, Copper, and Aluminum Nitride
Pezzotti, G., Ohgitani, E., Shin-Ya, M., Adachi, T., Marin, E., Boschetto, F., Zhu, W., Mazda, O.
10.1101/2020.06.19.159970 — Posted: 2020-06-20 Discussion: Onsite
Structural variability, expression profile and pharmacogenetics properties of TMPRSS2 gene as a potential target for COVID-19 therapy
Zarubin, A., Stepanov, V., Markov, A., Kolesnikov, N., Marusin, A., Khitrinskaya, I., Swarovskaya, M., Litvinov, S., Ekomasova, N., Dzhaubermezov, M., Maksimova, N., Sukhomyasova, A., Shtygasheva, O., Khusnutdinova, E., Radjabov, M., Kharkov, V.
10.1101/2020.06.20.156224 — Posted: 2020-06-20
Assessing uncertainty in the rooting of the SARS-CoV-2 phylogeny
Pipes, L., Wang, H., Huelsenbeck, J., Nielsen, R.
10.1101/2020.06.19.160630 — Posted: 2020-06-20
The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity and decreases neutralization sensitivity to individual convalescent sera
Hu, J., He, C. L., Gao, Q., Zhang, G. J., Cao, X. X., Long, Q. X., Deng, H. J., Huang, L. Y., Chen, J., Wang, K., Tang, N., Huang, A. L.
10.1101/2020.06.20.161323 — Posted: 2020-06-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).